Transdermal estradiol and testosterone transfer in man: existence, models, and strategies for prevention.
Transdermal hormone application allows delivery of a clinically relevant hormone dose often with fewer systemic side effects than oral formulations. However, transdermal hormone transfer from a dosed individual to naïve interpersonal contact occurs and may cause significant hormone imbalance and adverse effects. We reviewed PubMed, Medline, and Scopus articles from the years 1950 to 2010 for articles related to transdermal hormone transfer in the setting of in vivo and in vitro human and animal models. We used the following key words: transfer, transdermal, absorption, cutaneous, hormone, estradiol, and testosterone. Unpublished trials were reviewed on the US Food and Drug Administration (FDA) website for product approval. Data reflecting in vivo transfer of transdermal estradiol and testosterone in man is available from case reports, clinical trials, and FDA product information. While results clearly show that transfer can occur, methods for measuring the effect are not standardized and are thus difficult to compare among positive and negative studies. No in vitro human studies or animal models have been developed to specifically examine transfer potential of transdermal estradiol or testosterone. It is necessary to consider the mechanism behind transdermal hormone transfer and consider ways to enhance clinical benefits to the dosed individual while minimizing transfer to a naïve interpersonal contact. A detailed discussion of trial comparisons and future optimization methods may help enhance our understanding of the potential for transdermal hormone transfer and encourage development of newer formulations and/or application methods to minimize its occurrence.